The pandemic accelerated adoption of tech with long-standing promise, but where do we go from here. Join us on Jan. 19 for a discussion about where medtech companies and investors could find innovative new technologies in the future. We’ll hear from universities, private accelerator programs and others who will shed light on the new year.
The life sciences industry, like many others, has accelerated digital transformation as a result of the global pandemic, among other factors. Creating a digital revolution in healthcare, AI and other technological advancements are changing the customer experience globally – impacting patient treatments and outcomes. Thanks to the explosion of wearable and smart health devices, patients are more connected and have more data than ever before, right at their fingertips. It’s an exciting time in the industry, but certainly presents a new level of challenges.
Join Amplexor for a lively discussion with our panel of experts, Ann Cramer, Director of Digital Product Delivery and Operations at LifeScan; Ilyssa Levins, Regulatory Process Advisor for Digital Health; and Anand Iyer, Chief Strategy Officer at Welldoc as we dig into this topic! We’ll glean crucial knowledge from three key perspectives in the thick of digital transformation in life sciences.
As medical device and robotics technology mature and grow more capable they also become more complex, requiring focus on usability aspects from both a user experience (UX) design and regulatory perspective. These new applications, such as exoskeletons, demand a seamless interaction between the device and the user. That means designers and developers must improve utility while mitigating inherent risks.
This panel will explore how to approach UX design for medtech and how it should plug into a product development cycle leading to a 510(k) submission. We will share lessons learned from studying exoskeletons for military applications, and explain how they can be applied to medical/rehabilitative applications.
When taking a device from mind to market, you might have some ideas, processes and procedures in place, but it’s important to consider all possibilities. Knowing what may not work will bring you closer to knowing what will. Learn more while we explore the life cycle of the device.
COVID-19 has significantly changed the life sciences manufacturing industry, which may never be the same. And specifically, it has exposed weaknesses in manufacturing, such as supply chain problems, managing a remote workforce and inability to scale for or pivot to high demand products. Paper-based processes impede manufacturers’ ability to adapt product development and manufacturing to high-demand areas. Forward thinking companies need to adopt the right technology now to ensure they can adapt to the current environment and prepare for the future.
Attendees will learn how going digital across the product life cycle will help manufacturers be more flexible going forward and mitigate the risk of disruption.
As medical devices, combination products, and in-vitro diagnostics (IVD) are becoming increasingly important in the management and delivery of patient care, patient safety is of paramount concern. Now more than ever, having the proper framework for the collection and reporting of safety data to ensure both patient safety and efficacy during a clinical trial is essential.
During this presentation attendees will learn about the challenges and best practices for medical device clinical trial Safety Management, including Severe Adverse Event (SAE) data capture and cleaning to ensure uniform data for regulatory submissions and clinical data analysis.
Significant advancement in digital solutions, model-based development and regulatory pathways have been made in the medical and pharmaceutical devices and packaging industries recently. The net result can lead to faster and more predictable product development, higher reliability on market, more sustainable product and regulatory pathways that are safer, less expensive and faster. SES has 50+ years of developing credible models to support along the product lifecycle by leveraging validated tests, material characterization, industry experience and analysis expertise.
Engineering is an act of creation – a lot of folks get into this line of work explicitly because they want to create. In this webinar, speakers will talk about the light bulb moments of lone inspiration, and the more practical group efforts. Attendees will learn ways to build creative teams, the tools used to bring creativity into a work environment, and how those tools have changed during COVID.
Are you fully aware of your supply chain risks? Covid-19 caught the industry unprepared revealing the fragility of the supply chain, and the importance of planning and managing the risks. In this webinar we’ll demonstrate through Quasar case study how proper risk management led to stable supply chain during the Covid-19.
When you first embark on a new medical device development project, manufacturing can feel in the distance. However, manufacturing can have an impact on other stages of the product development process, from selecting a sterilization method to choosing the right materials. There are considerations to think about prior to kick-off to set your project up for future success.
The COVID-19 pandemic has forced decades old healthcare practices to be reshaped in just a few months, and the impact will be long lasting. This is particularly true in the medical device industry where reps can no longer depend on the ability to train and support clinicians in person. This panel will feature physician and industry representatives candidly discussing the challenges the medical device industry faces in the ‘new normal’ and the role that Procedural Telemedicine TM technology can play in helping the industry not just survive, but also thrive.
COVID-19 dramatically changed priorities for the medical device and supply industry. Initially, many companies shifted their efforts toward the production of key COVID – related supplies necessary to keep up with hospitalizations. But now, as states begin to reopen, hospitals are rapidly resuming scheduling elective procedures. This Device Talks Tuesday will dive into how medical companies are preparing for post-COVID demand as existing challenges, like lack of labor and order accuracy, are amplified by new health concerns, and social distancing requirements.
Covid-19 threaten to shut down your lab? Not a problem. Investor says years of your work isn’t worth investing in? What’s the big deal? Jeff Karp isn’t an optimist. He’s a realist. A realist who’s come to realize that bad news and disappointing outcomes can be the best motivator and teacher. In this DeviceTalks Tuesday discussion, Karp, a professor of medicine at Brigham and Women’s Hospital, Harvard Medical School, will share how researchers at his Karp Lab are able to convert criticism and disappointments into success.
Under the leadership of CEO Mick Farrell, respiratory leader Resmed has been a leader of bringing digital technology and monitoring to the patient and the bedside. In this keynote conversation, Farrell will walk us through Resmed’s approach and share its vision for the future. Questions and answers will follow the discussion led by Host Tom Salemi.
The pandemic didn’t eliminate the costs of developing a medtech device. Shrewd executives need to be able to tell their stories even under these trying circumstances to secure the capital their teams need. In this discussion, chief financial officers who have successfully raised massive rounds will detail their strategies.
Disruptive technology has been on the rise and with the current circumstances, adopting remote interaction in healthcare is critical to meet the needs of patients and consumers. Product redesign, virtual consultation and programming, and software are providing more opportunities in healthcare than ever before. To remain competitive, it’s imperative to recognize the changing opportunities, protect your IP, and do so with variable market demands.
The Covid-19 pandemic fueled the slow burning desires to build medical devices that can connect patients and providers. Going forward, new medical device technologies will need to demonstrate a well-conceived, fool-proof system that ensures medical care can’t be impeded by any future disruptions.
Now is the time for forward-thinking device firms to expand their offering and invest in services that support these groundbreaking new technologies.
CEOs from several companies appearing in Medical Design and Outsourcing’s “20 medical device startups you need to know” list will speak to the challenges facing startups. Attendees will hear how these medtech leaders are managing through difficult financial markets and finding ways to turning promising technologies into treatments.
Heidi Dohse, Sr. Program Manager at Google who works with the Cloud Healthcare & Life Sciences organization, is also a professional heart patient and the founder of Tour de Heart. In this discussion, Heidi will speak about her work to help medtech companies and patients improve the performance of their implanted devices. She partners with physicians and researchers around the world to provide insights regarding the patient experience and ideas for engagement. She travels globally educating audiences on digital health, data and healthcare.
Facing previously unforeseen shortages of personal protective equipment and supplies, provider systems like the Mayo Clinic enlisted engineering departments to help fill the materials gap with 3D printing and other approaches. With the surge in the rearview mirror, those hospital systems now are turning to those same teams to get their facilities ready for the return of patients. In this discussion, a panel of engineering and health professionals share how the venerable institution is moving to reopen in a safe and thoughtful manner.
MacuLogix CTO and co-founder Gregory Jackson jokes that he fainted when CEO Bill McPhee decided the company had to create an AI-enabled and wearable version of its revolutionary AdaptDx device used to diagnose macular degeneration. But the development of AdaptDx Pro went smoothly when Maculogix found the right partners like MPR Associates. In this discussion, Jackson and two principals from MPR – Jeff Champagne and Craig Mauch – will walk through the process that put the functionality of a benchtop system into a sleek, wearable device.
Professor Rogers will lay out his lab’s ongoing development of skin-interfaced, wireless wearables capable of ICU-grade monitoring, both in the clinic and the home. These advanced tools also support simultaneous capabilities in continuous tracking of novel metrics of patient health, with the ability to provide comprehensive, and potentially predictive, assessments of physiological status using advanced data analytics approaches.
The impact of COVID-19 hit medtech’s bottom line hard forcing companies to scale back on payroll through layoffs and salary cuts. But the sector will recover as hospitals learn to manage patient care in a pandemic. What can companies and medtech professionals do to ensure they’ve got the best team in place to succeed?
The medtech industry is being pressed to meet the many challenges presented by the pandemic. While medtech’s help is needed to create new tools and tests, the pandemic presents unprecedented challenges and opportunities for the industry.
In this discussion, our panel of experienced trial lawyers and IP counsel will discuss the following important and timely developments and trends: